Barclays

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Page 190 of 226
Genasys Inc.
Shares:30.7K
Value:$69.0K
% of Portfolio:0.0% ($69.0K/$175.9M)
62886HAX9
Shares:—
Value:$69.0K
% of Portfolio:0.0% ($69.0K/$175.9M)
76134H101
Shares:2.2K
Value:$69.0K
% of Portfolio:0.0% ($69.0K/$175.9M)
Liberty Global Ltd.
Shares:6.0K
Value:$68.0K
% of Portfolio:0.0% ($68.0K/$175.9M)
Artiva Biotherapeutics, Inc.
Shares:22.8K
Value:$68.0K
% of Portfolio:0.0% ($68.0K/$175.9M)
IOVANCE BIOTHERAPEUTICS, INC.
Shares:20.0K
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
33740U307
Shares:1.5K
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
Forge Global Holdings, Inc.
Shares:118.4K
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
78573NAE2
Shares:—
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
LEXICON PHARMACEUTICALS, INC.
Shares:146.1K
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
First Savings Financial Group, Inc.
Shares:2.6K
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
122017AD8
Shares:—
Value:$67.0K
% of Portfolio:0.0% ($67.0K/$175.9M)
Telomir Pharmaceuticals, Inc.
Shares:20.3K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
CASSAVA SCIENCES INC
Shares:44.1K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
Acrivon Therapeutics, Inc.
Shares:32.7K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
46435UAA9
Shares:2.7K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
33740F672
Shares:1.7K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
33740F862
Shares:1.4K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
Corbus Pharmaceuticals Holdings, Inc.
Shares:12.5K
Value:$66.0K
% of Portfolio:0.0% ($66.0K/$175.9M)
GYRE THERAPEUTICS, INC.
Shares:8.5K
Value:$65.0K
% of Portfolio:0.0% ($65.0K/$175.9M)